AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionKeel Point, LLC
Latest Disclosed Ownership10,907 shares
Latest Disclosed Value $ 2,372,067
Keel Point, LLC reports 7.80% decrease in ownership of 4AB / AbbVie Inc.

On May 29, 2026 - Keel Point, LLC filed a 13F-HR form disclosing ownership of 10,907 shares of AbbVie Inc. (DE:4AB) valued at $2,022,158 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 11,830 shares of AbbVie Inc.. This represents a change in shares of -7.80% during the quarter. The current value of the position is $2,055,970 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F ABBVIE COM 00287Y109 10,907 -923 -7.80 2,372 -12.25 0.1535
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 11,830 -38 -0.32 2,703 -1.60 0.1628
2025-12-16 2025-09-30 13F ABBVIE COM 00287Y109 11,868 -87 -0.73 2,748 23.79 0.1690
2025-08-15 2025-06-30 13F ABBVIE COM 00287Y109 11,955 476 4.15 2,219 -7.73 0.1467
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 11,479 1,204 11.72 2,405 31.78 0.1867
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 10,275 633 6.57 1,826 -4.15 0.1461
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 9,642 473 5.16 1,904 8.61 0.1586
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 9,169 2,925 46.84 1,753 54.18 0.1583
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 6,244 445 7.67 1,137 26.61 0.1176
2024-01-30 2023-12-31 13F ABBVIE COM 00287Y109 5,799 280 5.07 899 9.25 0.1073
2023-10-26 2023-09-30 13F ABBVIE COM 00287Y109 5,519 663 13.65 823 25.69 0.1128
2023-07-12 2023-06-30 13F ABBVIE COM 00287Y109 4,856 -406 -7.72 654 -21.96 0.0874
2023-04-03 2023-03-31 13F ABBVIE COM 00287Y109 5,262 1,593 43.42 839 41.55 0.1212
2023-01-17 2022-12-31 13F ABBVIE COM 00287Y109 3,669 663 22.06 593 46.53 0.0931
2022-10-05 2022-09-30 13F ABBVIE COM 00287Y109 3,006 24 0.80 404 -3.81 0.0693
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 2,982 448 17.68 420 2.19 0.0655
2022-04-27 2022-03-31 13F ABBVIE COM 00287Y109 2,534 81 3.30 411 23.80 0.0616
2022-01-31 2021-12-31 13F ABBVIE COM 00287Y109 2,453 178 7.82 332 35.51 0.0373
2021-11-04 2021-09-30 13F ABBVIE COM 00287Y109 2,275 -70 -2.99 245 -7.20 0.0317
2021-08-06 2021-06-30 13F/A-1 ABBVIE COM 00287Y109 2,345 2 0.09 264 3.94 0.0294
2021-08-06 2021-06-30 13F ABBVIE INC COM COM 00287Y109 250 -2,093 751 0.1743
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 2,343 282 13.68 254 14.93 0.0248
2021-02-10 2020-12-31 13F ABBVIE COM 00287Y109 2,061 2,061 -12.04 221 -12.99 0.0197
2019-05-14 2019-03-31 13F AbbVie COM 00287Y109 0 -4,492 -100.00 0 -100.00
2019-02-08 2018-12-31 13F AbbVie COM 00287Y109 4,492 0 0.00 414 -2.59 0.0560
2018-11-07 2018-09-30 13F AbbVie COM 00287Y109 4,492 1 0.02 425 2.16 0.0528
2018-08-13 2018-06-30 13F AbbVie COM 00287Y109 4,491 46 1.03 416 -1.19 0.0553
2018-05-07 2018-03-31 13F AbbVie COM 00287Y109 4,445 -1,967 -30.68 421 -32.10 0.0576
2018-02-08 2017-12-31 13F AbbVie COM 00287Y109 6,412 -900 -12.31 620 -4.62 0.0857
2017-11-09 2017-09-30 13F AbbVie COM 00287Y109 7,312 -1,109 -13.17 650 6.38 0.0990
2017-08-15 2017-06-30 13F AbbVie COM 00287Y109 8,421 220 2.68 611 14.42 0.1227
2017-05-15 2017-03-31 13F AbbVie COM 00287Y109 8,201 -290 -3.42 534 0.38 0.1079
2017-02-15 2016-12-31 13F AbbVie COM 00287Y109 8,491 1,107 14.99 532 14.16 0.1195
2016-11-15 2016-09-30 13F AbbVie COM 00287Y109 7,384 883 13.58 466 15.63 0.1770
2016-07-12 2016-06-30 13F AbbVie COM 00287Y109 6,501 6,501 -11.96 403 -13.52 0.1736
2016-05-13 2016-03-31 13F/A-1 AbbVie COM 00287Y109 0 -3,905 -100.00 0 -100.00
2016-02-04 2015-12-31 13F AbbVie COM 00287Y109 3,905 -728 -15.71 231 -8.33 0.1249
2015-11-04 2015-09-30 13F AbbVie COM 00287Y109 4,633 3 0.06 252 -21.74 0.1409
2015-07-31 2015-06-30 13F AbbVie COM 00287Y109 4,630 109 2.41 322 21.51 0.1535
2015-05-14 2015-03-31 13F AbbVie COM 00287Y109 4,521 4,521 265 0.1329
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.